1. T. F. Franke, ABL-Basic Research Program, National Cancer Institute-Frederick Cancer Research Facility and Development Center (NCI-FCRFDC), Frederick, MD 21702, USA; Montreal Neurological Institute, McGill University, PQ H3A 2B4, Canada; and Division of Signal Transduction, Beth Israel Hospital (BIH), Department of Cell Biology, Harvard Medical School (HMS), Boston, MA 02115, USA.
2. D. R. Kaplan, ABL-Basic Research Program, NCI-FCRFDC, Frederick, MD 21702, USA; and Montreal Neurological Institute, McGill University, Montreal, PQ H3A 2B4, Canada.
3. L. C. Cantley and A. Toker, Division of Signal Transduction, BIH, Department of Cell Biology, HMS, Boston, MA 02115, USA.